ReShape Lifesciences Inc (RSLS) — Financial Flexibility Index
ReShape Lifesciences Inc (RSLS) has a Financial Flexibility Index of -1.40x as of June 2025. Free cash flow of $-4.49 Million (operating CF $-4.49 Million minus capex $0.00) represents -1% of total liabilities ($3.20 Million). Check asset allocation strategy of ReShape Lifesciences Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ReShape Lifesciences Inc Financial Flexibility Index (2005–2024)
Historical Financial Flexibility Index trend for ReShape Lifesciences Inc across 20 annual periods. See ReShape Lifesciences Inc (RSLS) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ReShape Lifesciences Inc (2005–2024)
Year-by-year free cash flow to debt coverage for ReShape Lifesciences Inc. For the full company profile including market capitalisation, see ReShape Lifesciences Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.88x | $-4.43 Million | $-4.43 Million | $5.05 Million | ▲ +79.3% |
| 2023 | -4.23x | $-16.92 Million | $-16.96 Million | $4.00 Million | ▼ -45.3% |
| 2022 | -2.91x | $-21.77 Million | $-21.90 Million | $7.48 Million | ▼ -58.6% |
| 2021 | -1.84x | $-15.02 Million | $-15.38 Million | $8.19 Million | ▼ -407.7% |
| 2020 | -0.36x | $-8.16 Million | $-8.55 Million | $22.57 Million | ▲ +60.4% |
| 2019 | -0.91x | $-14.19 Million | $-14.20 Million | $15.55 Million | ▲ +51.4% |
| 2018 | -1.88x | $-27.44 Million | $-27.49 Million | $14.61 Million | ▲ +5.2% |
| 2017 | -1.98x | $-24.45 Million | $-24.59 Million | $12.34 Million | ▲ +60.6% |
| 2016 | -5.03x | $-20.64 Million | $-20.66 Million | $4.10 Million | ▼ -76.5% |
| 2015 | -2.85x | $-22.57 Million | $-22.61 Million | $7.91 Million | ▼ -14.1% |
| 2014 | -2.50x | $-19.29 Million | $-19.38 Million | $7.72 Million | ▼ -62.5% |
| 2013 | -1.54x | $-18.01 Million | $-18.43 Million | $11.71 Million | ▲ +2.4% |
| 2012 | -1.58x | $-22.40 Million | $-22.48 Million | $14.22 Million | ▲ +0.4% |
| 2011 | -1.58x | $-19.68 Million | $-19.94 Million | $12.44 Million | ▼ -4.0% |
| 2010 | -1.52x | $-13.66 Million | $-13.66 Million | $8.98 Million | ▲ +33.9% |
| 2009 | -2.30x | $-24.47 Million | $-24.66 Million | $10.63 Million | ▼ -16.2% |
| 2008 | -1.98x | $-33.42 Million | $-33.67 Million | $16.87 Million | ▼ -20.9% |
| 2007 | -1.64x | $-22.57 Million | $-23.37 Million | $13.77 Million | ▲ +21.3% |
| 2006 | -2.08x | $-15.59 Million | $-16.23 Million | $7.49 Million | ▼ -103.1% |
| 2005 | -1.03x | $-9.83 Million | $-10.28 Million | $9.59 Million | — |